Verification register Bio, Health & Neuro
Current reading
The readiness gap, in one scan
AI-assisted assembly · derived results
- Claimed
- 35
- Reported
- 31
- Verified
- 22
- Gap
- +13
Public ambition and stated capability
Observed practitioner reporting
Independently supported evidence
Claimed minus verified
Evidence strength Strong
Decision
What the current evidence supports
Human editorial judgment · 2026-06-28
Track; not yet
- Why
- Genuine regulatory milestone (FDA IDE, Apr 2026) and credible funding ($18.75M Series A; ARPA-H EVIDENT up to $139.4M program), but it is a first-in-human feasibility implant with zero human efficacy evidence — too early for any adoption, worth tracking as a frontier therapeutic-BCI signal.
- Next
- Watch for RESONATE 12-month safety readout and any first efficacy signal; monitor ARPA-H EVIDENT milestone reporting for response-data outcomes.
Constraints
Blockers
No named blocker is present in the current public projection.
Evidence summary
Derived counts
AI-assisted assembly
- Total
- 7
- Tier 1
- 2
- Tier 2
- 5
- Tier 3
- 0
- Supports
- 4
- Contradicts
- 2
- Context
- 1
- Latest observed
- 2026-05-06
Counts and dates only. Raw signals, private excerpts, trust records, and internal corpus material are not published here.
Publication record
Revisions
Initial public reading
This is the initial public reading. No earlier readiness change is recorded.